ANIX
Anixa Biosciences Inc

10,503
Mkt Cap
$96.13M
Volume
81,531.00
52W High
$5.46
52W Low
$2.33
PE Ratio
-8.55
ANIX Fundamentals
Price
$2.93
Prev Close
$2.88
Open
$2.86
50D MA
$3.25
Beta
1.16
Avg. Volume
235,150.20
EPS (Annual)
-$0.3367
P/B
6.27
Rev/Employee
$0.00
$117.85
Loading...
Loading...
News
all
press releases
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Analysts
Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned an average recommendation of "Hold" from the five brokerages that are covering the company, MarketBeat.com reports...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat Anixa Biosciences Announces Dr. Jose Conejo-Garcia will...
PR Newswire·1d ago
News Placeholder
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation Anixa Biosciences Reports Encouraging...
PR Newswire·15d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·17d ago
News Placeholder
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Recommendation of "Hold" from Brokerages
Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned a consensus rating of "Hold" from the five analysts that are covering the stock, MarketBeat reports. One investment...
MarketBeat·25d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Director Arnold Baskies Acquires 10,000 Shares
Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) Director Arnold Baskies purchased 10,000 shares of the business's stock in a transaction that occurred on Wednesday, January 28th. The shares...
MarketBeat·26d ago
News Placeholder
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology Anixa Biosciences Receives Notice of Allowance...
PR Newswire·28d ago
News Placeholder
Anixa Biosciences Inc (NASDAQ:ANIX) Short Interest Update
Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totaling 1,002,532 shares, an...
MarketBeat·1mo ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised Anixa Biosciences from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations
Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its earnings results on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of...
MarketBeat·1mo ago
<
1
2
...
>

Latest ANIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.